The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: Human immunodeficiency virus (HIV) infection is the strongest risk factor for developing tuberculosis and has fuelled its resurgence, especially in sub-Saharan Africa. In 2010, there were an estimated 1.1 million incident cases of tuberculosis among the 34 million people living with HIV worldwide. Antiretroviral therapy has substantial potential to prevent HIV-associated tuberculosis. We conducted a systematic review of studies that analysed the impact of antiretroviral therapy on the incidence of tuberculosis in adults with HIV infection. METHODS AND FINDINGS: PubMed, Embase, African Index Medicus, LILACS, and clinical trial registries were systematically searched. Randomised controlled trials, prospective cohort studies, and retrospective cohort studies were included if they compared tuberculosis incidence by antiretroviral therapy status in HIV-infected adults for a median of over 6 mo in developing countries. For the meta-analyses there were four categories based on CD4 counts at antiretroviral therapy initiation: (1) less than 200 cells/µl, (2) 200 to 350 cells/µl, (3) greater than 350 cells/µl, and (4) any CD4 count. Eleven studies met the inclusion criteria. Antiretroviral therapy is strongly associated with a reduction in the incidence of tuberculosis in all baseline CD4 count categories: (1) less than 200 cells/µl (hazard ratio [HR] 0.16, 95% confidence interval [CI] 0.07 to 0.36), (2) 200 to 350 cells/µl (HR 0.34, 95% CI 0.19 to 0.60), (3) greater than 350 cells/µl (HR 0.43, 95% CI 0.30 to 0.63), and (4) any CD4 count (HR 0.35, 95% CI 0.28 to 0.44). There was no evidence of hazard ratio modification with respect to baseline CD4 count category (p = 0.20). CONCLUSIONS: Antiretroviral therapy is strongly associated with a reduction in the incidence of tuberculosis across all CD4 count strata. Earlier initiation of antiretroviral therapy may be a key component of global and national strategies to control the HIV-associated tuberculosis syndemic. REVIEW REGISTRATION: International Prospective Register of Systematic Reviews CRD42011001209 Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
(2014) · Medical Entomology and Zoology · Cited by 17,633
Church, J. A. (2001) · Journal of Government Information · doi:10.1016/s1352-0237(01)00307-0 · Cited by 9,153
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
The Handbook of Research Synthesis.
Howel, D., Cooper, H., & Hedges, L. V. (1995) · Biometrics · doi:10.2307/2533295 · Cited by 3,642
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
Self-citationThe Handbook of Research Synthesis.
Light, R. J., Cooper, H., & Hedges, L. V. (1994) · Journal of the American Statistical Association · doi:10.2307/2291021 · Cited by 1,868
Global tuberculosis control 2010
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,262
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Self-citationTuberculosis control and elimination 2010–50: cure, care, and social development
Lönnroth, K., Castro, K. G., Chakaya, J. M., Chauhan, L. S., Floyd, K., Glaziou, P., & Raviglione, M. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60483-7 · Cited by 899
Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60936-1 · Cited by 780 · cited 1×
“Expansion of antiretroviral therapy may also reduce HIV incidence at the city [66,67], district [68,69], and national levels [70,71], while decreasing tuberculosis mortality [72–74] and HIVrelated mortality [75–78].”
BackgroundDas, M., Chu, P. L., Santos, G.-M., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011068 · Cited by 771
Treatment of latent tuberculosis infection in HIV infected persons
Akolo, C., Adetifa, I., Shepperd, S., & Volmink, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000171.pub3 · Cited by 713
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
Gilks, C. F., Crowley, S., Ekpini, R., Gove, S., Perriens, J., Souteyrand, Y., Sutherland, D., Vitoria, M., Guerma, T., & De Cock, K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69158-7 · Cited by 689
Human Development Report 2011. Sustainability and Equity: A Better Future for AllPreprint
Klugman, J. (2011) · SSRN Electronic Journal · Cited by 675
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A., Gengiah, T., Nair, G., Bamber, S., Singh, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905848 · Cited by 666
Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
Blanc, F.-X., Sok, T., Laureillard, D., Borand, L., Rekacewicz, C., Nerrienet, E., Madec, Y., Marcy, O., Chan, S., Prak, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013911 · Cited by 612
The Population Dynamics and Control of Tuberculosis
Dye, C., & Williams, B. G. (2010) · Science · doi:10.1126/science.1185449 · Cited by 604
Self-citationBadri, M., Wilson, D., & Wood, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08904-3 · Cited by 556
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Havlir, D. V., Kendall, M. A., Ive, P., Kumwenda, J., Swindells, S., Qasba, S. S., Luetkemeyer, A. F., Hogg, E., Rooney, J. F., Wu, X., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013607 · Cited by 532
A consistent log-linear relationship between tuberculosis incidence and body mass index
Lonnroth, K., Williams, B. G., Cegielski, P., & Dye, C. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp308 · Cited by 455
Self-citationDiagnostic Standards and Classification of Tuberculosis
Friedman, L. N. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.4_pt_1.895a · Cited by 431
Getahun, H., Kittikraisak, W., Heilig, C. M., Corbett, E. L., Ayles, H., Cain, K. P., Grant, A. D., Churchyard, G. J., Kimerling, M., Shah, S., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000391 · Cited by 404
Self-citationDiagnostic Standards and Classification of Tuberculosis
(1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.725 · Cited by 401
Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti
Severe, P., Jean Juste, M. A., Ambroise, A., Eliacin, L., Marchand, C., Apollon, S., Edwards, A., Bang, H., Nicotera, J., Godfrey, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910370 · Cited by 377
Trends in tuberculosis incidence and their determinants in 134 countries
Dye, C., Lönnroth, K., Jaramillo, E., Williams, B., & Raviglione, M. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.058453 · Cited by 364
Self-citationSamandari, T., Agizew, T. B., Nyirenda, S., Tedla, Z., Sibanda, T., Shang, N., Mosimaneotsile, B., Motsamai, O. I., Bozeman, L., Davis, M. K., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60204-3 · Cited by 355
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
Abu-Raddad, L. J., Sabatelli, L., Achterberg, J. T., Sugimoto, J. D., Longini, I. M., Dye, C., & Halloran, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901720106 · Cited by 348
Self-citationLawn, S. D., Myer, L., Edwards, D., Bekker, L.-G., & Wood, R. (2009) · AIDS · doi:10.1097/qad.0b013e32832d3b6d · Cited by 338
Self-citationAntiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
Anglemyer, A., Rutherford, G. W., Horvath, T., Baggaley, R. C., Egger, M., & Siegfried, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009153.pub3 · Cited by 249
The HIV-associated tuberculosis epidemic—when will we act?
Harries, A. D., Zachariah, R., Corbett, E. L., Lawn, S. D., Santos-Filho, E. T., Chimzizi, R., Harrington, M., Maher, D., Williams, B. G., & De Cock, K. M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60409-6 · Cited by 244
Self-citationThe HIV-CAUSAL Collaboration* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-8-201104190-00001 · Cited by 235
Sweat, M., Morin, S., Celentano, D., Mulawa, M., Singh, B., Mbwambo, J., Kawichai, S., Chingono, A., Khumalo-Sakutukwa, G., Gray, G., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70060-3 · Cited by 224
Cock, K. M. D., & Chaisson, R. E. (1999) · PubMed · Cited by 214
Self-citationInterventions to reduce tuberculosis mortality and transmission in low- and middle-income countries.
Borgdorff, M. W., Floyd, K., & Broekmans, J. F. (2002) · Europe PMC (PubMed Central) · Cited by 212
The Antiretroviral Therapy Cohort Collaboration (2005) · Clinical Infectious Diseases · doi:10.1086/498315 · Cited by 203
Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral Therapy
Lawn, S. D., Wilkinson, R. J., Lipman, M. C. I., & Wood, R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1311pp · Cited by 202
Self-citationLawn, S. D., Wood, R., De Cock, K. M., Kranzer, K., Lewis, J. J., & Churchyard, G. J. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70078-5 · Cited by 180
Self-citationSantoro-Lopes, G., Felix de Pinho, A. M., Harrison, L. H., & Schechter, M. (2002) · Clinical Infectious Diseases · doi:10.1086/338641 · Cited by 167
Writing Committee for the CASCADE Collaboration* (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.401 · Cited by 128
Lawn, S. D., Harries, A. D., Williams, B. G., Chaisson, R. E., Losina, E., Cock, K. M. D., & Wood, R. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0483 · Cited by 119
Self-citationRie, A. V., Westreich, D. J., & Sanne, I. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181f9fb39 · Cited by 107
Lawn, S. D., Kranzer, K., Edwards, D., McNally, M., Bekker, L., & Wood, R. (2010) · AIDS · doi:10.1097/qad.0b013e3283390dd1 · Cited by 106
Self-citationAntiretroviral therapy for tuberculosis control in nine African countries
Williams, B. G., Granich, R., Cock, K. M. D., Glaziou, P., Sharma, A., & Dye, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005660107 · Cited by 100
Self-citationAntiretroviral Therapy in Prevention of HIV and TB: Update on Current Research Efforts
Granich, R., Gupta, S., Suthar, A. B., Smyth, C., Hoos, D., Vitória, M., Simão, M. B. G., Hankins, C. A., Schwartländer, B., Ridzon, R., et al. (2011) · Current HIV Research · doi:10.2174/157016211798038597 · Cited by 99
Self-citationAntiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
Anglemyer, A. T., Rutherford, G. W., Baggaley, R. C., Egger, M., & Siegfried, N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009153.pub2 · Cited by 90
Moulton, L. H., Golub, J. E., Durovni, B., Cavalcante, S. C., Pacheco, A. G., Saraceni, V., King, B., & Chaisson, R. E. (2007) · Clinical Trials · doi:10.1177/1740774507076937 · Cited by 82
Self-citationJerene, D., Næss, A., & Lindtjørn, B. (2006) · AIDS Research and Therapy · doi:10.1186/1742-6405-3-10 · Cited by 80
Podlekareva, D. N., Mocroft, A., Dragsted, U. B., Ledergerber, B., Beniowski, M., Lazzarin, A., Weber, J. N., Clumeck, N., Vetter, N., Phillips, A. N., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/506366 · Cited by 79
Lugada, E., Millar, D., Haskew, J., Grabowsky, M., Garg, N., Vestergaard, M., Kahn, J., Muraguri, N., & Mermin, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012435 · Cited by 73 · cited 1×
“A cluster-randomised trial recently found that community-based HIV testing detects approximately four times as many people with HIV as health-facility-based testing alone [83], and a 1-wk community-based multi-disease campaign recently tested 47,311 Kenyans (87% of the target sexually active population 15–49 y of age)…”
BackgroundCollaborationa, T. H.-C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis203 · Cited by 70
BMJ Publishing Group Ltd (2008) · Sexually Transmitted Infections · doi:10.1136/sti.2008.029793 · Cited by 69
Uy, J. P., Armon, C., Buchacz, K. A., Wood, K. C., & Brooks, J. T. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181acb630 · Cited by 58
Antiretroviral Therapy and TB Notification Rates in a High HIV Prevalence South African Community
Middelkoop, K., Bekker, L., Myer, L., Johnson, L. F., Kloos, M., Morrow, C. D., & Wood, R. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31820413b3 · Cited by 57
Dembélé, M., Saleri, N., Carvalho, A., Saouadogo, T., Hien, A., Zabsonre, I., Koala, S., Simporè, J., & Matteelli, A. (2010) · PubMed · Cited by 48
Bärnighausen, T., Tanser, F. C., Dabis, F., & Newell, M. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834fc1df · Cited by 40
Stable Incidence of HIV Diagnoses Among Danish MSM Despite Increased Engagement in Unsafe Sex
Cowan, S. A., Gerstoft, J., Haff, J., Christiansen, A. H., Nielsen, J. C., & Obel, N. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825af890 · Cited by 37
Tuberculosis in HIV programmes in lower-income countries: practices and risk factors
Fenner, L., Forster, M., Boulle, A., Phiri, S., Braitstein, P. K. A., Lewden, C., Schechter, M., Kumarasamy, N., Pascoe, M. J., Sprinz, E., et al. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0249 · Cited by 36
Suthar, A. B., Klinkenberg, E., Ramsay, A., Garg, N., Bennett, R., Towle, M. S., Sitienei, J. K., Smyth, C., Daniels, C., Baggaley, R. C., et al. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0480 · Cited by 8
Self-citation
Cited by
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Self-citationA Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
The TEMPRANO ANRS 12136 Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507198 · Cited by 1,242
Getahun, H., Matteelli, A., Abubakar, I., Aziz, M. A., Baddeley, A., Barreira, D., Den Boon, S., Borroto Gutierrez, S. M., Bruchfeld, J., Burhan, E., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01245-2015 · Cited by 596
Self-citationGrinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., Wang, L., Ou, S.-S., Anderson, M., McCauley, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70692-3 · Cited by 494
Gupta, R. K., Lucas, S. B., Fielding, K. L., & Lawn, S. D. (2015) · AIDS · doi:10.1097/qad.0000000000000802 · Cited by 371
Self-citation
Metadata
- Authors
- Suthar, A. B., Lawn, S. D., del Amo, J., Getahun, H., Dye, C., Sculier, D., Sterling, T. R., Chaisson, R. E., Williams, B. G., Harries, A. D., & Granich, R. M.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-07-24
- Volume
- 9
- Issue
- 7
- Pages
- e1001270
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2144386728
- Cited by
- 402
- References
- 66
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.